Viewing Study NCT00735332


Ignite Creation Date: 2025-12-24 @ 9:30 PM
Ignite Modification Date: 2026-02-09 @ 2:41 AM
Study NCT ID: NCT00735332
Status: TERMINATED
Last Update Posted: 2010-08-05
First Post: 2008-08-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy Study of TLN-232 in Patients With Recurring Metastatic Melanoma
Sponsor: Thallion Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module